| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.0019 | 1 |